Jan Wolfe

May 31, 2014 | Litigation Daily

Lawyers at Hollingsworth have mostly defeated claims over DynCorp's antidrug crop spraying in South America two decades ago. But the long-running litigation isn't quite over, thanks to an appeals court ruling issued on Friday.

By Jan Wolfe

3 minute read

May 31, 2014 | Litigation Daily

Lawyers at Hollingsworth have mostly defeated claims over DynCorp's antidrug crop spraying in South America two decades ago. But the long-running litigation isn't quite over, thanks to an appeals court ruling issued on Friday.

By Jan Wolfe

3 minute read

May 31, 2014 | International Edition

Venezuela has been a challenging legal market ever since Hugo Chavez frightened off Western investment a decade ago. These challenges have continued in the year since Chavez's death, as his handpicked successor, Nicolás Maduro, follow in his footsteps and violent clashes between pro-government militants and protesters become more common.

By Jan Wolfe

5 minute read

May 30, 2014 | Litigation Daily

The patent litigation playbook has changed dramatically over the past two decades. But according to a trio of academics and patent experts, the average win-loss record has barely budged.

By Jan Wolfe

3 minute read

May 29, 2014 | Litigation Daily

Neuman made a name for herself exposing fraud on the part of plaintiffs lawyers suing Dole over its pesticide use in Latin America. This week, she finished off nearly all the remaining cases in a more old-fashioned way, winning a ruling that Dole's opponents waited too long to sue.

By Jan Wolfe

5 minute read

May 29, 2014 | The American Lawyer

As suits stemming from the financial crisis end, the New York firm's profits fall.

By Jan Wolfe

16 minute read

May 29, 2014 | The American Lawyer

The company tries (again) to get rid of its court-appointed antitrust monitor.

By Jan Wolfe

3 minute read

May 28, 2014 | Litigation Daily

A proposed class action against Morgan Stanley has served as a petri dish for key issues in mortgage-backed securities litigation, with mixed results for both sides.

By Jan Wolfe

4 minute read

May 28, 2014 | Litigation Daily

The German drug company and its lawyers at Covington & Burling were facing their first trial in September over claims that the drug thinner Pradaxa caused patients to bleed out.

By Jan Wolfe

3 minute read

May 27, 2014 | Litigation Daily

Akin Gump said last week that LBDS Holding Company admitted to fabricating evidence at the heart of a $25 million jury verdict. In its haste to flee the case, did the firm reveal too much about its former client's conduct?

By Jan Wolfe

3 minute read